NPPA outcome data
The data on this page relates to applications received in last four financial years.
2020–2024 data
The table below gives the number of applications and the result of the application by chemical for the last four years. The Excel spreadsheet download provides indications (by chemical), where providing this information will not impact anyone's privacy.
2020–2024 NPPA outcome data (including indications) [XLSX, 97 KB]
If you have questions about a specific chemical or indication, email nppa@pharmac.govt.nz
| Chemical | Approved | Declined | Principles not met | Withdrawn | Grand Total |
|---|---|---|---|---|---|
| 4-aminopyridine | 5 | 2 | 7 | ||
| adalimumab | 24 | 6 | 10 | 40 | |
| alirocumab | 12 | 2 | 14 | ||
| alitretinoin | 1 | 7 | 1 | 9 | |
| amifampridine [3,4-diaminopyridine] | 7 | 7 | |||
| amino acid formula | 4 | 1 | 2 | 7 | |
| amino acid formula (without isoleucine, leucine and valine) | 10 | 10 | |||
| amino acid formula low calcium | 8 | 8 | |||
| anakinra | 23 | 5 | 3 | 31 | |
| apixaban | 6 | 1 | 7 | ||
| aprepitant | 12 | 3 | 1 | 16 | |
| aripiprazole | 6 | 1 | 7 | ||
| asparaginase | 28 | 1 | 29 | ||
| atezolizumab | 1 | 1 | 16 | 1 | 19 |
| azacitidine | 27 | 1 | 2 | 30 | |
| azithromycin | 6 | 3 | 3 | 12 | |
| bedaquiline | 35 | 2 | 37 | ||
| bendamustine hydrochloride | 4 | 3 | 7 | ||
| bevacizumab | 29 | 13 | 1 | 43 | |
| biotin | 14 | 14 | |||
| blinatumomab | 28 | 1 | 2 | 31 | |
| bortezomib | 11 | 1 | 1 | 13 | |
| brentuximab vedotin | 38 | 8 | 1 | 47 | |
| budesonide | 2 | 4 | 1 | 7 | |
| cannabinoid | 7 | 35 | 4 | 46 | |
| ceftazidime and avibactam | 9 | 1 | 10 | ||
| ciclosporin eye preparations | 241 | 7 | 1 | 249 | |
| cinacalcet | 3 | 16 | 6 | 25 | |
| continuous glucose monitor | 24 | 17 | 3 | 44 | |
| crizotinib | 5 | 2 | 7 | ||
| dabrafenib | 12 | 4 | 1 | 17 | |
| danazol | 8 | 3 | 11 | ||
| daratumumab | 2 | 5 | 7 | ||
| deferasirox | 4 | 4 | 4 | 12 | |
| denosumab | 19 | 23 | 2 | 44 | |
| dexamethasone eye preparations | 1 | 8 | 9 | ||
| dipyridamole | 11 | 11 | |||
| dulaglutide | 4 | 3 | 3 | 10 | |
| dupilumab | 8 | 15 | 4 | 27 | |
| eculizumab | 5 | 2 | 9 | 4 | 20 |
| elexacaftor/tezacaftor/ivacaftor | 3 | 3 | 1 | 7 | |
| eltrombopag | 13 | 6 | 3 | 22 | |
| emicizumab | 4 | 8 | 1 | 13 | |
| empagliflozin | 5 | 11 | 1 | 17 | |
| enoxaparin sodium | 19 | 4 | 6 | 29 | |
| epoetin alfa | 5 | 1 | 3 | 9 | |
| etanercept | 12 | 4 | 6 | 22 | |
| everolimus | 10 | 3 | 1 | 14 | |
| fluoxetine hydrochloride | 4 | 3 | 2 | 9 | |
| galcanezumab | 2 | 7 | 9 | ||
| ganciclovir eye preparations | 12 | 2 | 14 | ||
| gemtuzumab ozogamicin | 5 | 3 | 8 | ||
| ibrutinib | 4 | 21 | 25 | ||
| indomethacin | 19 | 2 | 1 | 22 | |
| infliximab | 34 | 19 | 6 | 59 | |
| inotuzumab ozogamicin | 6 | 3 | 9 | ||
| insulin pump | 6 | 1 | 9 | 16 | |
| insulin pump consumables | 5 | 5 | 10 | ||
| isotretinoin | 16 | 16 | |||
| ivabradine | 6 | 14 | 1 | 21 | |
| ketamine | 30 | 1 | 31 | ||
| ketotifen | 5 | 3 | 8 | ||
| lacosamide | 6 | 2 | 8 | ||
| lamotrigine | 252 | 83 | 10 | 345 | |
| lenalidomide | 25 | 5 | 4 | 34 | |
| letermovir | 6 | 1 | 7 | ||
| levetiracetam | 56 | 1 | 5 | 62 | |
| levocarnitine | 5 | 3 | 8 | ||
| levofloxacin | 8 | 1 | 1 | 10 | |
| linezolid | 31 | 2 | 1 | 34 | |
| liraglutide | 1 | 15 | 16 | ||
| macitentan | 11 | 3 | 1 | 15 | |
| melatonin | 1 | 11 | 1 | 13 | |
| meningococcal (a, c, y and w-135) conjugate vaccine | 8 | 8 | |||
| mepolizumab | 7 | 7 | 3 | 17 | |
| methylphenidate hydrochloride | 1 | 6 | 2 | 9 | |
| midostaurin | 2 | 1 | 3 | 1 | 7 |
| mitotane | 22 | 22 | |||
| moxifloxacin | 16 | 3 | 2 | 21 | |
| multivitamin and mineral supplement | 1 | 5 | 1 | 7 | |
| naltrexone hydrochloride | 1 | 8 | 1 | 10 | |
| nelarabine | 8 | 2 | 10 | ||
| nintedanib | 1 | 6 | 2 | 9 | |
| nirmatrelvir with ritonavir | 1 | 3 | 6 | 10 | |
| nivolumab | 6 | 6 | 1 | 13 | |
| obinutuzumab | 4 | 3 | 2 | 9 | |
| octreotide lar | 7 | 5 | 3 | 15 | |
| olanzapine | 1 | 1 | 18 | 20 | |
| olaparib | 16 | 8 | 24 | ||
| omalizumab | 10 | 3 | 3 | 16 | |
| oral feed liquid | 1 | 10 | 11 | ||
| oral feed paediatric renal | 7 | 7 | |||
| palivizumab | 1 | 4 | 3 | 8 | |
| pazopanib | 15 | 8 | 1 | 24 | |
| pegylated interferon alfa-2a | 10 | 3 | 2 | 15 | |
| pegylated liposomal doxorubicin hydrochloride | 5 | 20 | 25 | ||
| pembrolizumab | 26 | 37 | 2 | 65 | |
| perampanel | 8 | 5 | 5 | 18 | |
| ponatinib | 10 | 1 | 3 | 14 | |
| posaconazole | 35 | 3 | 2 | 40 | |
| potassium citrate | 6 | 5 | 11 | ||
| pristinamycin | 39 | 1 | 40 | ||
| prucalopride | 18 | 16 | 3 | 37 | |
| retinol (vitamin a) | 425 | 2 | 6 | 433 | |
| ribavirin | 6 | 1 | 2 | 9 | |
| rifaximin | 2 | 7 | 9 | ||
| rituximab | 144 | 45 | 23 | 212 | |
| rufinamide | 34 | 1 | 35 | ||
| ruxolitinib | 22 | 12 | 1 | 35 | |
| sargramostim | 22 | 22 | |||
| secukinumab | 17 | 11 | 3 | 31 | |
| selexipag | 6 | 9 | 15 | ||
| sirolimus | 28 | 2 | 2 | 32 | |
| sirolimus | 13 | 1 | 14 | ||
| sitafloxacin | 10 | 10 | |||
| sodium chloride | 3 | 13 | 1 | 17 | |
| sofosbuvir with velpatasvir | 5 | 1 | 1 | 7 | |
| sorafenib | 9 | 3 | 12 | ||
| stanozolol | 35 | 1 | 36 | ||
| sunitinib | 6 | 3 | 2 | 11 | |
| tacrolimus | 13 | 7 | 10 | 30 | |
| tadalafil | 11 | 8 | 1 | 20 | |
| taurolidine and citrate | 4 | 5 | 9 | ||
| temozolomide | 29 | 4 | 33 | ||
| teriparatide | 5 | 6 | 11 | ||
| thalidomide | 16 | 2 | 18 | ||
| tinidazole | 18 | 18 | |||
| tobramycin | 1 | 6 | 3 | 10 | |
| tocilizumab | 79 | 22 | 10 | 111 | |
| tofacitinib | 9 | 10 | 1 | 20 | |
| topotecan | 26 | 1 | 27 | ||
| trametinib | 47 | 9 | 1 | 57 | |
| trastuzumab | 5 | 9 | 1 | 15 | |
| upadacitinib | 25 | 23 | 2 | 50 | |
| ursodeoxycholic acid | 5 | 2 | 2 | 9 | |
| ustekinumab | 7 | 15 | 2 | 24 | |
| valganciclovir | 23 | 23 | |||
| varicella zoster vaccine | 8 | 8 | 16 | ||
| vedolizumab | 4 | 8 | 1 | 13 | |
| vemurafenib | 6 | 1 | 1 | 8 | |
| venetoclax | 14 | 1 | 30 | 3 | 48 |
| venlafaxine | 1 | 5 | 2 | 8 | |
| vinorelbine | 8 | 1 | 9 | ||
| voriconazole | 21 | 2 | 23 | ||
| zonisamide | 44 | 5 | 49 | ||
| (blank) | |||||
| Grand Total | 2808 | 9 | 973 | 294 | 4084 |